NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 230 filers reported holding NEKTAR THERAPEUTICS in Q3 2022. The put-call ratio across all filers is 0.14 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $2,615,265 | +100025.0% | 3,720,679 | +221.9% | 0.00% | -25.0% |
| Q4 2022 | $2,612 | -99.9% | 1,155,873 | +34.4% | 0.00% | 0.0% |
| Q3 2022 | $2,753,000 | +110.5% | 860,218 | +149.9% | 0.00% | +100.0% |
| Q2 2022 | $1,308,000 | +1667.6% | 344,243 | +2400.5% | 0.00% | – |
| Q1 2022 | $74,000 | -60.2% | 13,767 | 0.0% | 0.00% | – |
| Q4 2021 | $186,000 | -24.7% | 13,767 | 0.0% | 0.00% | – |
| Q3 2021 | $247,000 | – | 13,767 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HARVEY CAPITAL MANAGEMENT INC | 598,400 | $10,083,000 | 3.98% |
| Opus Point Partners Management, LLC | 348,583 | $5,874,000 | 3.88% |
| Camber Capital Management LP | 3,500,000 | $58,975,000 | 3.81% |
| 1492 Capital Management LLC | 180,601 | $3,043,000 | 2.21% |
| Virtus ETF Advisers LLC | 38,260 | $645,000 | 1.77% |
| Cormorant Asset Management, LP | 765,156 | $12,893,000 | 1.54% |
| Rhenman & Partners Asset Management AB | 581,000 | $9,790,000 | 1.48% |
| Granahan Investment Management | 2,082,155 | $35,084,000 | 1.21% |
| BRIDGER MANAGEMENT, LLC | 1,563,862 | $26,351,000 | 0.87% |
| RICE HALL JAMES & ASSOCIATES, LLC | 899,531 | $15,157,000 | 0.87% |